Response to Kujawa et al. letter-to-the-editor.
Gopalan
G
Sethuraman
Cindy C
CC
Taylor
Mark
M
Enerson
Eduardo
E
Dunayevich
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D012074:Remission Induction; D012559:Schizophrenia / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome
D014150:Antipsychotic Agents